Post-earnings recap
Reported
Wed, Apr 22, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Thermo Fisher Scientific reported an EPS that fell short of expectations, leading to a significant surprise. Despite this, the stock rose by 5%, likely driven by investor optimism about the company's resilience in challenging times. The lack of guidance may leave some investors cautious as they assess future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.97 | N/A | -29.42% |
Management acknowledged the difficulties faced during the quarter. They emphasized the importance of operational efficiency in the current environment.
We are navigating through challenging market conditions.
Our focus remains on maintaining operational efficiency.